Lev Silberstein, MD, PhD

faculty member

Lev Silberstein, MD, PhD

Associate Professor
Translational Science and Therapeutics Division, Fred Hutch

Fax: 206.667.6124
Mail Stop: 01-100

Dr. Lev Silberstein studies factors that regulate the behavior of normal and malignant stem cells in the bone marrow. He and his colleagues aim to develop new ways to boost blood cell production in patients with blood disorders, inherited bone marrow failure and those recovering from blood stem cell transplants.

Other Appointments & Affiliations

Attending Hematologist
Fred Hutchinson Cancer Center

Associate Professor, Division of Hematology and Oncology
University of Washington School of Medicine


PhD, University of Cambridge

MBBS equivalent, King’s College School of Medicine and Dentistry

MD, Novosibirsk Medical Institute

Research Interests

Micro-environmental control of hematopoietic stem/progenitor quiescence

Restoration of hematopoietic stem cell function in bone marrow failure

Development of therapeutic strategies to enhance post-transplant reconstitution

Current Projects

Characterization of novel extrinsic regulators of hematopoietic stem cell/progenitor quiescence

Pharmacological modulation of hematopoietic stem cell quiescence to restore hematopoiesis in myelodysplasia (funded by Leukemia and Lymphoma Society Translational Research Program Award)

Find a Clinical Trial

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email media@fredhutch.org or call 206.667.2210